Combination therapy in the treatment of pulmonary arterial hypertension - 2015 update.
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 4
Abstract
Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of combining drugs from two or more classes. They can be applied sequentially or initially (upfront). Data from randomized clinical placebo controlled trials and observational studies show that both strategies can be successful in terms of improvement of functional capacity or delaying time to clinical worsening. The European Society of Cardiology guidelines on pulmonary hypertension issued in 2015 present in detail the role of combination therapy in the management of PAH.
Authors and Affiliations
Grzegorz Kopec, Piotr Podolec
Keywords
Related Articles
- EP ID EP242018
- DOI 10.20418/jrcd.vol2no4.204
- Views 125
- Downloads 0
Report from the 12th Meeting of the Myocardial and Pericardial Diseases Working Group of the European Society of Cardiology, 2015 in Florence, Italy
Nowadays, with a constant accumulation of data and knowledge, specialized and dedicated to particular problems meetings are thriving. The Working Group (WG) of the Myocardial and Peri‑ cardial Diseases of the European So...
Myocardial infarction in Fabry disease – misfortune or companion? Case report and review of the literature
We discuss a 56‑year‑old man with Fabry disease (FD), a genetic X‑linked glycolipid storage disorder. The patient presented at the Emergency Room in a local hospital due to tachycardia‑associated chest pain, which had oc...
Desmin – related restrictive cardiomyopathy (RCD code: III-3E)
Desmin – related myopathy is a chronic neuromuscular disorder caused by a mutation of desmin, an intermediate filament of the myocardial, skeletal, and smooth muscles. Clinical manifestations include skeletal myopathy, c...
Development of the European Network in Orphan Cardiovascular Diseases. EU Project inauguration
Both international and Polish cardiology community warmly welcomed our prior international project entitled Establishing a European Network for Orphan Cardiovascular Diseases (European Regional Development Fund and Małop...
Wunderlich’s syndrome associated with anticoa gulant treatment, heart failure, and post‐radiation vasculopathy
Background: Wunderlich’s syndrome (WS) is an extremely rare condition, characterised by spontaneous haemorrhage into the subcapsular, perirenal, and retroperitoneal spaces. The most common cause is renal angiomyolipoma....